🔗 Permalink

Assignee profile:

CSL Behring Lengnau AG

City:

Lengnau

Country:

Switzerland

Published Applications:

Last publication date:

2021-09-02

Patent Grants:

Last grant date:

2024-02-06

Top Inventors for applications by CSL Behring Lengnau AG

These are the the leading inventors for applications assigned to CSL Behring Lengnau AG:

Sabine PESTEL 7 Marburg, Germany
Thomas Weimer 7 Gladenbach, Germany
Stefan Schulte 5 Marburg, Germany
Hubert Metzner 3 Marburg, Germany

Steve DOWER 3 Fitzroy North, Australia
Arna ANDREWS 2 Kew East, Victoria, Australia
Steve DOWER 2 Fitzroy North, Victoria, Australia
Kerstin EMMRICH 2 Preston, Victoria, Australia

Arna Andrews 2 Kew East, Australia
Michael WILSON 2 Elwood, Victoria, Australia
Con Panousis 2 Bundoora, Australia
Hans-Wilhelm BELTZ 2 Biedenkopf, Germany

Dallas HARTMAN 2 Niddrie, Victoria, Australia
Matthew Hardy 2 Doreen, Australia
Matthias PELZING 2 Thomastown, Australia
Dallas Hartman 2 Niddrie, Australia

Matthew HARDY 2 Doreen, Victoria, Australia
Kerstin Emmrich 2 Preston, Australia
Michael Wilson 2 Elwood, Australia
Eugene Maraskovsky 1 Kew, Australia

Con PANOUSIS 1 Bundoora, Victoria, Australia
Huy HUYNH 1 Brunswick, Australia
Uwe Kalina 1 Marburg, Germany
Michael Moses 1 Graevenwiesbach, Germany

Marco HOFMANN 1 Lahntal-Sterzhausen, Germany
Tobias BRANDT 1 Marburg, Germany
Carsten Horn 1 Marburg, Germany
Anne VERHAGEN 1 Northcote, Australia

Thomas NOWAK 1 Staufenberg, Germany
Elmar RAQUET 1 Frankenberg, Germany
Gerhard DICKNEITE 1 Marburg, Germany
Con PANOUSIS 1 Parkville, Victoria, Australia

Recent patent applications by CSL Behring Lengnau AG

CSL Behring Lengnau AG based in Lengnau, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-09-02 ✅ Patent 11,890,327 granted on 2024-02-06

US20210268071A1

Human necessities

Truncated von Willebrand factor polypeptides for extravascular administration in the treatment or prophylaxis of a blood coagulation disorder

#2 | 2020-11-26 ✅ Patent 10,905,747 granted on 2021-02-02

US20200368327A1

Human necessities

Methods for preparing modified von Willebrand factor

#3 | 2020-10-08 ✅ Patent 11,479,578 granted on 2022-10-25

US20200317727A1

Chemistry; metallurgy

Protein purification and virus inactivation with alkyl glycosides

#4 | 2020-06-25 ✅ Patent 11,141,466 granted on 2021-10-12

US20200197495A1

Human necessities

Modulation of FVIII immunogenicity by truncated VWF

#5 | 2019-08-29 ✅ Patent 11,814,421 granted on 2023-11-14

US20190263890A1

Chemistry; metallurgy

Truncated von Willebrand Factor polypeptides for treating hemophilia

#6 | 2019-01-17 ✅ Patent 10,808,023 granted on 2020-10-20

US20190016784A1

Chemistry; metallurgy

Mutated von Willebrand factor

#7 | 2019-01-17 ✅ Patent 10,806,774 granted on 2020-10-20

US20190015483A1

Human necessities

Mutated truncated von Willebrand Factor

#8 | 2018-06-14 ✅ Patent 10,688,157 granted on 2020-06-23

US20180161402A1

Human necessities

Truncated von Willebrand factor polypeptides for treating hemophilia

#9 | 2018-06-07 ✅ Patent 10,772,936 granted on 2020-09-15

US20180153968A1

Human necessities

Methods for preparing modified von Willebrand factor

#10 | 2018-02-22 ✅ Patent 11,155,601 granted on 2021-10-26

US20180051067A1

Chemistry; metallurgy

Modified von Willebrand factor having improved half-life

Also check out CSL BEHRING LENGNAU AG's (Lengnau, Switzerland) applicant profile with 12 patent applications submitted.

AssigneeID:

352629 ⎘